title: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Murray
authors.forename: Jay
authors.initials: J
authors.lastname: Cowen
authors.forename: Heidi
authors.initials: H
authors.lastname: DeBlock
authors.forename: Brian
authors.initials: B
authors.lastname: Erstad
authors.forename: Anthony W
authors.initials: AW
authors.lastname: Gray
authors.forename: Ann N
authors.initials: AN
authors.lastname: Tescher
authors.forename: William T
authors.initials: WT
authors.lastname: McGee
authors.forename: Richard C
authors.initials: RC
authors.lastname: Prielipp
authors.forename: Greg
authors.initials: G
authors.lastname: Susla
authors.forename: Judith
authors.initials: J
authors.lastname: Jacobi
authors.forename: Stanley A
authors.initials: SA
authors.lastname: Nasraway
authors.forename: Philip D
authors.initials: PD
authors.lastname: Lumb
mesh_terms: D000328:Adult; D003422:Critical Care / Q000592:standards*; D016638:Critical Illness; D006801:Humans; D008991:Monitoring, Physiologic / Q000592:standards; D019148:Neuromuscular Blockade / Q000592:standards*; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000502:physiology
chemical_list: D009466:Neuromuscular Blocking Agents